Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial

PHILIP J. MEASE, STANLEY COHEN, NORMAN B. GAYLIS, ANDREW CHUBICK, ALAN T. KAELL, MARIA GREENWALD, SUNIL AGARWAL, MING YIN and ARIELLA KELMAN
The Journal of Rheumatology May 2010, 37 (5) 917-927; DOI: https://doi.org/10.3899/jrheum.090442
PHILIP J. MEASE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pmease@nwlink.com
STANLEY COHEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORMAN B. GAYLIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREW CHUBICK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALAN T. KAELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA GREENWALD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUNIL AGARWAL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MING YIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARIELLA KELMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 37 no. 5 917-927
DOI 
https://doi.org/10.3899/jrheum.090442
PubMed 
20194448

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication December 1, 2009
  • Published online May 3, 2010.

Article Versions

  • Latest version (March 1, 2010 - 07:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2010

Author Information

  1. PHILIP J. MEASE,
  2. STANLEY COHEN,
  3. NORMAN B. GAYLIS,
  4. ANDREW CHUBICK,
  5. ALAN T. KAELL,
  6. MARIA GREENWALD,
  7. SUNIL AGARWAL,
  8. MING YIN and
  9. ARIELLA KELMAN
  1. From Seattle Rheumatology Associates, Swedish Medical Center, Seattle, Washington; Metroplex Clinical Research Center and Arthritis Centers, Dallas, Texas; Desert Medical Advances, Palm Desert; Genentech Inc., South San Francisco, California; Arthritis and Rheumatic Disease Specialties, Aventura, Florida; and Rheumatology Associates, Port Jefferson Station, New York, USA.
  2. P.J. Mease, MD, Seattle Rheumatology Associates, Swedish Medical Center; S. Cohen, MD, Metroplex Clinical Research Center; N.B. Gaylis, MD, Arthritis and Rheumatic Disease Specialties; A. Chubick, MD, Arthritis Centers; A.T. Kaell, MD, Rheumatology Associates; M. Greenwald, MD, Desert Medical Advances; S. Agarwal, MD; M. Yin, PhD; A. Kelman, MD, Genentech Inc.
  1. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 1101 Madison St., Suite 1000, Seattle, WA 98104, USA. E-mail: pmease{at}nwlink.com

Article usage

Article usage: February 2010 to April 2022

AbstractFullPdf
Feb 2010201
Mar 20105390291
Apr 20101365141
May 2010126753189
Jun 20102273669
Jul 20101362537
Aug 20101412340
Sep 20101242031
Oct 20101053233
Nov 2010712428
Dec 2010531922
Jan 2011622229
Feb 2011591623
Mar 2011842027
Apr 2011581725
May 2011751520
Jun 2011661017
Jul 2011651523
Aug 2011771433
Sep 2011581626
Oct 2011661526
Nov 201155412
Dec 20113647
Jan 2012591216
Feb 2012341116
Mar 20123668
Apr 2012441012
May 201237815
Jun 201243610
Jul 2012351219
Aug 2012501219
Sep 2012501411
Oct 2012422024
Nov 201219914
Dec 20122769
Jan 2013651115
Feb 2013561518
Mar 2013411016
Apr 201329413
May 2013231411
Jun 201327616
Jul 2013311219
Aug 20132079
Sep 201331716
Oct 20132456
Nov 20131338
Dec 20131055
Jan 20142034
Feb 20142159
Mar 20141635
Apr 20143225
May 20141276
Jun 20142299
Jul 20141769
Aug 20141278
Sep 2014371216
Oct 2014151211
Nov 201415119
Dec 20143748
Jan 20151966
Feb 201529915
Mar 2015281313
Apr 20151559
May 2015301410
Jun 201522810
Jul 20152186
Aug 201523912
Sep 20151246
Oct 20151755
Nov 2015251112
Dec 2015161211
Jan 20162378
Feb 201632810
Mar 2016201211
Apr 2016241311
May 20162859
Jun 20163338
Jul 20162767
Aug 20162667
Sep 20163046
Oct 2016271014
Nov 2016271011
Dec 201635510
Jan 20176389
Feb 2017641413
Mar 2017651917
Apr 201745116
May 20175854
Jun 20174764
Jul 20175776
Aug 201744106
Sep 201738147
Oct 20175441
Nov 20174877
Dec 20173544
Jan 20184343
Feb 20183033
Mar 201833106
Apr 20184555
May 20185382
Jun 20185398
Jul 20183573
Aug 20184685
Sep 20184732
Oct 20186565
Nov 20185374
Dec 201840105
Jan 20195275
Feb 20195065
Mar 20194074
Apr 20195185
May 20191551
Jun 20195768
Jul 20192587
Aug 20197454
Sep 20194755
Oct 20195152
Nov 20197784
Dec 20193061
Jan 20201723
Feb 202042911
Mar 202051913
Apr 202063315
May 202033712
Jun 202002015
Jul 202035113
Aug 202091917
Sep 20205206
Oct 202061820
Nov 202055810
Dec 202073014
Jan 20212259
Feb 202111225
Mar 202134513
Apr 20216239
May 2021383514
Jun 20219218
Jul 202143216
Aug 202115616
Sep 20215388
Oct 20211469
Nov 20217498
Dec 2021103613
Jan 202259426
Feb 20223229
Mar 202219215
Apr 202222357

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 37, Issue 5
1 May 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
PHILIP J. MEASE, STANLEY COHEN, NORMAN B. GAYLIS, ANDREW CHUBICK, ALAN T. KAELL, MARIA GREENWALD, SUNIL AGARWAL, MING YIN, ARIELLA KELMAN
The Journal of Rheumatology May 2010, 37 (5) 917-927; DOI: 10.3899/jrheum.090442

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
PHILIP J. MEASE, STANLEY COHEN, NORMAN B. GAYLIS, ANDREW CHUBICK, ALAN T. KAELL, MARIA GREENWALD, SUNIL AGARWAL, MING YIN, ARIELLA KELMAN
The Journal of Rheumatology May 2010, 37 (5) 917-927; DOI: 10.3899/jrheum.090442
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire